Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page
- Check2 days agoChange DetectedThe page revision label has been updated from v3.6.0 to v3.6.2. This reflects a recent update to the page's revision metadata and does not modify the visible study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoChange DetectedThe page adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) to guide users, and it updates the recruitment status to show that no participants are being sought, along with a minor formatting/name change to the Intervention/Treatment label and a revision note.SummaryDifference0.4%

- Check24 days agoChange DetectedRevision label updated to v3.5.5, indicating a new iteration of the page. There is no apparent user-facing content change accompanying this update.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page displays a new Revision: v3.5.4, replacing the previous v3.5.3, indicating a new version of the study documentation.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a technical site update rather than a change to the trial’s published content.SummaryDifference0.1%

- Check74 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.